Jns Hndsn:Glb Lf Sci;I (JFNIX.O)

At A Glance

You hold JFNIX.O in 0 portfolios

Net Asset Value


 -0.07 -0.12%


World Equity
YTD Return (Cumulative)
GL Health/Biotech
5 Year Return (Annualized)
Manager Benchmark
Lipper Gl Hlth/Biotch IX
Lipper Leader Profile (Overall)
Total Return
Consistent Return
Capital Preservation
Low Expense
Tax Efficiency(U.S. only)

Growth of $10,000 since June, 2009 »


The Growth of $10,000 chart includes reinvestment of dividends and capital gains, but does not reflect the effect of any applicable sales or redemption charges which would lower these figures.

Fund Profile

Fund FamilyJanus Capital Management LLC
Inception Date07/06/2009
Portfolio Turnover41%
Dividend Yield--
Fund ManagerAcker/Lovell
Manager Tenure2009
Janus Capital Management LLC
151 Detroit Street
Denver, CO 80206-4805

Fees, Expenses, & Minimums

Load TypeInstitutional
Total Expense Ratio0.78%
Max 12b-1 Fee Ratio--
Early Redemption Fee0.00%
Initial Investment$1,000,000
Subsequent Investments--
Initial IRA Investments--
Subsequent IRA Investments--

Investment Strategy

The Fund seeks long-term growth of capital by investing at least 80% of its assets on companies engaged in research development, production or distribution of products or services related to health and personal care, medicine or pharmaceuticals.

Overall Lipper Leaders Ratings & Fund Profile »

Total Return
Consistent Return
Capital Preservation
Low Expense
Tax Efficiency (U.S. only)

About the ratings...

Total Return reflects the fund's historical total return performance relative to its peers. Consistent Return reflects the funds's historical risk-adjusted returns relative to its peers. The Capital Preservation is relative, rather that absolute...More »

Lipper Leaders.com
View Overview Page For